Human Immunoglobulins for intravenous use and hepatitis C viral transmission.
作者信息
Slade H B
机构信息
Department of Allergy/Immunology/AIDS, Rhône-Poulenc Rorer, Collegeville, Pennsylvania, USA.
出版信息
Clin Diagn Lab Immunol. 1994 Nov;1(6):613-9. doi: 10.1128/cdli.1.6.613-619.1994.
Abstract
摘要
相似文献
1
Human Immunoglobulins for intravenous use and hepatitis C viral transmission.
Clin Diagn Lab Immunol. 1994 Nov;1(6):613-9. doi: 10.1128/cdli.1.6.613-619.1994.
2
Hepatitis C virus transmission by intravenous immunoglobulin.
Lancet. 1995 Aug 5;346(8971):373; author reply 374-5.
3
Hepatitis C virus transmission by intravenous immunoglobulin.
Lancet. 1995 Aug 5;346(8971):374; author reply 374-5.
4
Hepatitis C transmission associated with intravenous immunoglobulins.
Lancet. 1995 May 6;345(8958):1173-4. doi: 10.1016/s0140-6736(95)91002-6.
5
Immunoglobulin transmits hepatitis C. True or false?
Hepatology. 1999 Jan;29(1):299-300. doi: 10.1002/hep.510290137.
6
Hepatitis C transmission associated with intravenous immunoglobulins.
Lancet. 1995 May 6;345(8958):1174.
7
Administration of immune serum globulin following exposure to hepatitis C virus.
Clin Infect Dis. 1993 Feb;16(2):335. doi: 10.1093/clind/16.2.335.
8
Specific immunoglobulin against hepatitis C virus. Why not?
Infez Med. 2012 Sep;20(3):214-6.
9
Safety of intravenous immunoglobulin treatment.
J Clin Pathol. 1985 Oct;38(10):1192-3. doi: 10.1136/jcp.38.10.1192.
10
Immunoglobulin preparation: safe from virus transmission?
Vox Sang. 1989;57(1):1-3. doi: 10.1111/j.1423-0410.1989.tb04974.x.
引用本文的文献
1
Pharmacokinetic and Pharmacodynamic Considerations for the Use of Monoclonal Antibodies in the Treatment of Bacterial Infections.
Antibodies (Basel). 2018 Jan 4;7(1):5. doi: 10.3390/antib7010005.
2
The Capsular Polysaccharide of Acinetobacter baumannii Is an Obstacle for Therapeutic Passive Immunization Strategies.
Infect Immun. 2017 Nov 17;85(12). doi: 10.1128/IAI.00591-17. Print 2017 Dec.
3
Subcutaneous immunoglobulin for primary and secondary immunodeficiencies: an evidence-based review.
Drugs. 2013 Aug;73(12):1307-19. doi: 10.1007/s40265-013-0094-3.
4
Passive antibody administration (immediate immunity) as a specific defense against biological weapons.
Emerg Infect Dis. 2002 Aug;8(8):833-41. doi: 10.3201/eid0808.010516.
5
Back to the future: antibody-based strategies for the treatment of infectious diseases.
Mol Biotechnol. 2002 Jul;21(3):225-39. doi: 10.1385/MB:21:3:225.
6
Recognition and management of myositis.
Drugs. 1997 Jul;54(1):39-49. doi: 10.2165/00003495-199754010-00003.
7
Antibody-based therapies for emerging infectious diseases.
Emerg Infect Dis. 1996 Jul-Sep;2(3):200-8. doi: 10.3201/eid0203.960306.
本文引用的文献
1
Large scale production of human plasma fractions. Eight years experience with the alcohol fractionation procedure of Nitschmann, Kistler and Lergier.
Vox Sang. 1962 Jul-Aug;7:414-24. doi: 10.1111/j.1423-0410.1962.tb03274.x.
2
Hepatitis C from immunoglobin infusions.
BMJ. 1993 Jun 5;306(6891):1541-2. doi: 10.1136/bmj.306.6891.1541-c.
3
Non-A, non-B post-transfusion hepatitis. Looking back in the second decade.
Ann Intern Med. 1993 Jul 15;119(2):110-5. doi: 10.7326/0003-4819-119-2-199307150-00003.
4
Transmission of hepatitis after the administration of intravenous immunoglobulins.
Am J Clin Pathol. 1993 May;99(5):649. doi: 10.1093/ajcp/99.5.649.
5
Chronic liver disease due to hepatitis C.
BMJ. 1993 Apr 17;306(6884):1054-6. doi: 10.1136/bmj.306.6884.1054.
6
Clinical, biochemical and histological features in 102 patients with chronic hepatitis C virus infection.
Q J Med. 1993 Feb;86(2):119-25.
7
Failure to detect hepatitis C virus (HCV) genome by polymerase chain reaction in human anti-HCV-positive intravenous immunoglobulins.
Clin Exp Immunol. 1993 May;92(2):205-10. doi: 10.1111/j.1365-2249.1993.tb03381.x.
8
Consequences of chronic hepatitis C: a review article for the hematologist.
Am J Hematol. 1993 Sep;44(1):29-37. doi: 10.1002/ajh.2830440107.
9
Viral hepatitis in health care personnel at The Johns Hopkins Hospital. The seroprevalence of and risk factors for hepatitis B virus and hepatitis C virus infection.
Arch Intern Med. 1993 Jul 26;153(14):1705-12.
10
Chronic hepatitis C after high-dose intravenous immunoglobulin.
Transfusion. 1994 Jan;34(1):86-7. doi: 10.1046/j.1537-2995.1994.34194098618.x.
Zotero 插件